Google-backed Tempus AI pops by as much as 15% in Nasdaq stock market debut
Publishing timestamp: 2024-06-14 12:26:33
Summary
Tempus AI rose by 15% in its market debut on Nasdaq after going public. The Chicago-based health-care diagnostics company uses AI to interpret medical tests to help physicians provide more accurate treatment for their patients. The company priced 11 million shares at $37 apiece, raising $410 million at an implied valuation of just over $6 billion. CEO Eric Lefkofsky expects the company to be cash flow and EBITDA positive within the next year.
Sentiment: POSITIVE
Tickers: TEM?QSEARCHTERM=TEM, GRPN,
Keywords: groupon inc, ipo, technology, health, health care industry, suppress zephr, business news, tempus ai inc, artificial intelligence,